Sanofi (SNY)

34.31 +0.08  +0.23%  May 25, 11:00PM Go Pro
Watch this stock
View Full Chart SNY Price Chart

Key Stats

Market Cap 92.01B
Revenue Growth -1.54%
Profit Margin 21.47%
Earnings Yield 9.41%
Dividend Yield 4.90%
Earnings Per Share TTM 3.23
PE Ratio 10.62
Price / Sales Ratio 1.954
52 Week High 40.58
52 Week Low 30.98
Beta 0.8593
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 25 Engulfing candles if ur long $spy n search of set ups. $glw $jcp $htz $vlo $gfi $wdc $gt $sny $amtd $kr $vmed $tso $pmcs $leap $idti $nxy by Good2go
May 25 Amylin Shares Jump as Sanofi, Merck Sumbit Bids Benzinga
May 25 Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make F...
May 22 Has Momenta Pharmaceuticals Become the Perfect Stock? Fool
May 22 Buffett and Woodford Agree on This One! Fool
May 20 Bristol-Myers Squibb's Thud Heard Round the World Fool
May 18 At its current valuation $FB is larger than these companies $MCD $RIO $VALE $CSCO $SLB $V $BTI $SNY $SI $C - Really unbelievable IMO by sld1986
May 18 Generic Versions of Plavix Get FDA Approval Investor Place
May 18 A.M. Vitals: FDA OKs Generic Plavix
May 18 Dr. Reddy’s Labs (RDY) Launches Generic Plavix Tabs (SNY) Street Insider
May 17 $SNY Not gonna pick the bottom here, but this is looking ripe by NYC12
May 16 $SNY why all the call interest today? Todays most active Options Sanofi 99.6% calls wow... http://stks.co/3qwq by justfurkids
May 15 The Drama Continues At $AMLN: Takeover Still Likely. $BMY $LLY $SNY http://stks.co/3prL by abubnic

Profile

Exchange: NYSE       Sector: Healthcare       Industry: Drug Manufacturers - Major

Sanofi S.A. is a multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines . Sanofi is a full member of the European Federation of Pharmaceutical Industries and Associations . The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo. It changed its name to Sanofi in May 2011. The company was founded in 1970.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sanofi is down 6.32% over the last year vs S&P 500 Total Return up 2.03%, Pfizer up 10.35%, and AstraZeneca Group down 15.26%.

  • SNY Total Returns
  • ^SPXTR Total Returns
  • PFE Total Returns
  • AZN Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring SNY

Did Sanofi make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

SNY Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
SNY 34.31 +0.08 +0.23% 92.01B
SNPS 29.89 +0.04 +0.13% 4.358B
SNP 90.85 +0.14 +0.15% 86.14B
SNMX 2.33 -0.04 -1.69% 92.66M
SNH 20.78 -0.03 -0.14% 3.380B
SNE 13.30 -0.46 -3.34% 13.35B
SNCR 17.85 -0.05 -0.28% 687.58M
SMTC 24.08 +0.38 +1.60% 1.575B
SMSC 36.55 -0.02 -0.05% 812.51M
SMS 10.81 -1.05 -8.85% 2.225B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close